14.62

1.67% 0.24

After Hours: 14.62

Immunome Inc (IMNM)

Overview News Price History Option Chain Financials Discussions Forecast

Immunome Inc stock is traded at $14.62, with a volume of 888.88K. It is up +1.67% in the last 24 hours and down -3.69% over the past month. Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which itcan efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious disease, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP) and and IM-4320.

Previous Close:

$14.38

Open:

$14.39

24h Volume:

888.88K

Relative Volume:

1.16

Market Cap:

$863.59M

Revenue:

Net Income/Loss:

$-106.81M

P/E Ratio:

-6.6455

EPS:

-2.2

Net Cash Flow:

$-8.40M

1W Performance:

+4.43%

1M Performance:

-3.69%

6M Performance:

-40.76%

1Y Performance:

+75.09%

1-Day Range:

$14.30

$14.83

1-Week Range:

$13.91

$15.20

52-Week Range:

$6.93

$30.96

Immunome Inc Stock (IMNM) Company Profile

Name

Immunome Inc

Sector

Healthcare (1190)

Industry

Biotechnology (681)

Phone

610-321-3700

Address

18702 N. CREEK PARKWAY, BOTHELL

Employee

Twitter

Next Earnings Date

2024-09-02

Latest SEC Filings

IMNM's Discussions on Twitter

Immunome Inc Stock (IMNM) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
May-31-24	Initiated	Piper Sandler	Overweight
Apr-30-24	Initiated	JP Morgan	Overweight
Apr-15-24	Initiated	Guggenheim	Buy
Jan-29-24	Initiated	Leerink Partners	Outperform
Dec-19-23	Initiated	Wedbush	Outperform
Oct-29-21	Initiated	Cantor Fitzgerald	Overweight

View All

Immunome Inc Stock (IMNM) Latest News

11:32 AM

Daily Market Movement: Immunome Inc (IMNM) Sees a 0.28 Increase, Closing at 14.38 - The Dwinnex

11:32 AM

05:52 AM

Immunome, Inc. (NASDAQ:IMNM) Short Interest Update - MarketBeat

05:52 AM

01:19 AM

Northeast Financial Consultants Inc Buys Shares of 72,953 Immunome, Inc. (NASDAQ:IMNM) - Defense World

01:19 AM

Sep 29, 2024

Ensign Peak Advisors Inc Makes New Investment in Immunome, Inc. (NASDAQ:IMNM) - MarketBeat

Sep 29, 2024

Sep 27, 2024

Insider Selling: Rosett Max, Immunome Inc [IMNM] Chief Financial Officer divested 14,380 shares - Knox Daily

Sep 27, 2024

Closing Figures Unveiled: Immunome Inc (IMNM) Drop -6.60, Closes at 14.00 - The Dwinnex

Sep 24, 2024

Rhumbline Advisers Purchases Shares of 67,184 Immunome, Inc. (NASDAQ:IMNM) - MarketBeat

Sep 24, 2024

Rhumbline Advisers Acquires Shares of 67,184 Immunome, Inc. (NASDAQ:IMNM) - Defense World

Sep 24, 2024

Sep 23, 2024

Analysts review Immunome Inc’s rating - Knox Daily

Sep 23, 2024

Immunome (NASDAQ:IMNM) Shares Down 5.6% on Insider Selling - MarketBeat

Sep 23, 2024

Immunome (NASDAQ:IMNM) Shares Down 5.6% After Insider Selling - Defense World

Sep 23, 2024

Sep 21, 2024

Max Rosett Sells 14,380 Shares of Immunome, Inc. (NASDAQ:IMNM) Stock - MarketBeat

Sep 21, 2024

Immunome, Inc. (NASDAQ:IMNM) CFO Max Rosett Sells 14,380 Shares - Defense World

Sep 21, 2024

Immunome (NASDAQ:IMNM) Sees Strong Trading Volume - Defense World

Sep 21, 2024

Sep 20, 2024

Immunome CFO sells shares valued at over $230,000 By Investing.com - Investing.com South Africa

Sep 20, 2024

Immunome CFO sells shares valued at over $230,000 - Investing.com

Sep 20, 2024

How To Trade (IMNM) - Stock Traders Daily

Sep 20, 2024

Primecap Management Co. CA Buys 55,800 Shares of Immunome, Inc. (NASDAQ:IMNM) - MarketBeat

Sep 20, 2024

Sep 19, 2024

Immunome (NASDAQ:IMNM) Sees Strong Trading Volume - MarketBeat

Sep 19, 2024

Primecap Management Co. CA Purchases 55,800 Shares of Immunome, Inc. (NASDAQ:IMNM) - Defense World

Sep 19, 2024

IMNM Stock Sees Surge of Approximately 7.19% in Last Five Days - Knox Daily

Sep 19, 2024

Sep 18, 2024

Immunome, Inc. (NASDAQ:IMNM) Short Interest Up 5.9% in August - Defense World

Sep 18, 2024

Gaining Ground: Immunome Inc (IMNM) Closes Lower at 15.40, Down -2.47 - The Dwinnex

Sep 18, 2024

Does Immunome Inc (IMNM) offer a good opportunity for investors? - SETE News

Sep 18, 2024

Bank of New York Mellon Corp Invests $1.82 Million in Immunome, Inc. (NASDAQ:IMNM) - MarketBeat

Sep 18, 2024

Quest Partners LLC Takes $81,000 Position in Immunome, Inc. (NASDAQ:IMNM) - Defense World

Sep 18, 2024

Bank of New York Mellon Corp Takes $1.82 Million Position in Immunome, Inc. (NASDAQ:IMNM) - Defense World

Sep 18, 2024

Sep 17, 2024

Immunome (NASDAQ:IMNM) Shares Down 3.3% - MarketBeat

Sep 17, 2024